• Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$162.36
▼ -2.3 (-1.40%)

This chart shows the closing price for NOVT by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Novanta Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for NOVT and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for NOVT

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Novanta in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $162.36.

This chart shows the closing price for NOVT for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 contributing investment analysts is to n/a stock in Novanta. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/30/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/28/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/29/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/27/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/25/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/23/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/23/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/23/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/11/2023Robert W. BairdBoost Target$150.00 ➝ $161.00Low
5/11/2022William BlairUpgradeMarket Perform ➝ OutperformLow
9/3/2021Robert W. BairdReiterated RatingHoldLow
11/13/2020Berenberg BankInitiated CoverageHold$109.00Low
5/13/2020Robert W. BairdBoost TargetNeutral$80.00 ➝ $90.00High
4/2/2020William BlairDowngradeOutperform ➝ Market PerformHigh
(Data available from 5/23/2019 forward)

News Sentiment Rating

0.78 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 9 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
10/26/2023
  • 4 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/25/2023
  • 7 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/25/2023
  • 5 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/24/2024
  • 7 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/23/2024
  • 16 very positive mentions
  • 11 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
3/24/2024
  • 7 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
4/23/2024
  • 8 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/23/2024

Current Sentiment

  • 8 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Novanta logo
Novanta Inc., together with its subsidiaries, provides precision medicine and manufacturing, medical solutions, and robotics and automation solutions in the United States and internationally. The company operates through three segments: Precision Medicine and Manufacturing, Medical Solutions, and Robotics and Automation. The Precision Medicine and Manufacturing segment offers photonics-based solutions, including laser scanning, beam delivery, CO2 laser, solid state laser, ultrafast laser, and optical light engine products serving photonics-based applications for industrial processing, metrology, medical and life science imaging, DNA sequencing, and medical laser procedures. The Medical Solutions segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; wireless technologies, video recorders, and video integration technologies for operating room integrations; optical data collection and machine vision technologies; radio frequency identification technologies; thermal chart recorders; spectrometry technologies; and embedded touch screen solutions. The Robotics and Automation segment offers optical and inductive encoders, precision motors, servo drives and motion control solutions, integrated stepper motors, intelligent robotic end-of-arm technology solutions, air bearings, and air bearing spindles. The company sells its products through its direct sales force and distributors under the Cambridge Technology, Synrad, Laser Quantum, ARGES, WOM, NDS, Med X Change, Reach Technology, JADAK, ThingMagic, Photo Research, General Scanning, ATI Industrial Automation, Celera Motion, IMS, MicroE, Applimotion, Zettlex, Ingenia, and Westwind brands. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was incorporated in 1968 and is headquartered in Bedford, Massachusetts.
Read More

Today's Range

Now: $162.36
Low: $161.29
High: $165.25

50 Day Range

MA: $164.62
Low: $149.41
High: $175.68

52 Week Range

Now: $162.36
Low: $111.20
High: $187.60

Volume

106,091 shs

Average Volume

131,832 shs

Market Capitalization

$5.83 billion

P/E Ratio

84.12

Dividend Yield

N/A

Beta

1.35

Frequently Asked Questions

What sell-side analysts currently cover shares of Novanta?

The following Wall Street analysts have issued stock ratings on Novanta in the last twelve months: StockNews.com, and TheStreet.
View the latest analyst ratings for NOVT.

What is the current price target for Novanta?

0 Wall Street analysts have set twelve-month price targets for Novanta in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Novanta in the next year.
View the latest price targets for NOVT.

What is the current consensus analyst rating for Novanta?

Novanta currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for NOVT.

What other companies compete with Novanta?

How do I contact Novanta's investor relations team?

Novanta's physical mailing address is 125 Middlesex Turnpike, Bedford MA, 01730. The technology company's listed phone number is (781) 266-5700 and its investor relations email address is [email protected]. The official website for Novanta is www.novanta.com. Learn More about contacing Novanta investor relations.